Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2)
Psychotherapy and Psychosomatics · 13.11.2026
DOI: 10.1159/pps/aemag025 ↗Kurz gefasst
Fachartikel in der Zeitschrift Psychotherapy and Psychosomatics, online erschienen am 13.11.2026. Verfasst von Ailsa Russell und 19 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression
Abstract (Originalsprache)
Introduction
Autistic people are disproportionately affected by depression and access recommended first line treatments such as Guided Self-Help (GSH)) which has not been developed to meet their needs. This study aims to test the effectiveness of autism adapted GSH for depression compared to treatment as usual.
Methods
A two parallel group multi-centre randomised controlled trial investigated the effectiveness of GSH adapted for autism. The RCT was registered on 09th August 2022 (ISRCTN: 17547011). Adults, ≥18 years, with a confirmed autism diagnosis and symptoms of depression (PHQ-9 ≥ 10) recruited from community settings were randomised to GSH or Treatment as Usual (TAU). Adapted GSH comprised psychoeducation and behavioural activation supported by nine meetings with a coach. Beck Depression Inventory (BDI-II) scores at 16-weeks post-randomisation were analysed on an intention to treat basis. Additional measures at 16-weeks captured anxiety, well-being and service use with follow up at 32- and 52-weeks.
Results
Participants (n=266) were randomised to GSH (n=132) or TAU (n=134). Of participants randomised to GSH, 110 (81%) completed the minimum 6 session dose, five did not begin the intervention and 28 discontinued. Estimated between group mean difference in BDI-II scores at 16 weeks was -5.05 (95% CI: -7.85 to -2.24, P<0.001, d=0.47) in favour of GSH, with the difference sustained at 52-weeks.
Conclusion
The intervention named Autism Affirming Accompanied Self-Help for depression (AASH-DEP) needs to be rolled-out so clinicians and autistic people can be confident to access effective treatment for depression adapted for autism.
Autor:innen und Institutionen
ORCID-Profile: Chris Metcalfe
Zitieren
APA
Russell, A., Vazquez-Morales, M., Cooper, K., Dagnan, D., Langdon, P. E., Metcalfe, C., Horwood, J., Ingham, B., Rai, D., Thorn, J., Wiles, N., Kessler, D., Cotton, L., Georgakopoulou, A., Realpe, A. X., Garfield, K., Chopra, M., Aldridge, R., Cape, A., & Jervis, V. (2026). Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2). Psychotherapy and Psychosomatics. https://doi.org/10.1159/pps/aemag025
Vancouver
Russell A, Vazquez-Morales M, Cooper K, Dagnan D, Langdon PE, Metcalfe C, et al. Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2). Psychotherapy and Psychosomatics. 2026. doi:10.1159/pps/aemag025
BibTeX
@article{Russell2026,
author = {Russell, Ailsa and Vazquez-Morales, Maximiliano and Cooper, Kate and Dagnan, Dave and Langdon, Peter E and Metcalfe, Chris and Horwood, Jeremy and Ingham, Barry and Rai, Dheeraj and Thorn, Joanna and Wiles, Nicola and Kessler, David and Cotton, Leonora and Georgakopoulou, Aikaterini and Realpe, Alba X and Garfield, Kirsty and Chopra, Mannat and Aldridge, Rona and Cape, Alison and Jervis, Vicky},
title = {Guided self-help for depression adapted for autistic adults: a multi-centre randomised controlled phase 3 trial (ADEPT-2)},
journal = {Psychotherapy and Psychosomatics},
year = {2026},
doi = {10.1159/pps/aemag025}
}
EUVIMED